Image_1_Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3).JPEG by Vania A. Figueroa (8332773)

Table_1_Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3).DOCX by Vania A. Figueroa (8332773)

Table_1_Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3).DOCX by Vania A. Figueroa (8332773)

Image_2_Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3).TIF by Vania A. Figueroa (8332773)

Image_2_Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3).TIF by Vania A. Figueroa (8332773)

Image_1_Contribution of Connexin Hemichannels to the Decreases in Cell Viability Induced by Linoleic Acid in the Human Lens Epithelial Cells (HLE-B3).JPEG by Vania A. Figueroa (8332773)

liver tissue, stained with H&E, of (a) normal rats showing normal hepatic parenchyma with normal hepatocytes, (b) TAA-treated group showing disrupted hepatic parenchyma, with massi... by Sally A. El Awdan (710176)

Orsay virus infection of the <i>lin-8(n2731</i>) synMuv A mutant induces a Muv phenotype indicative of decreased synMuv B gene activity, and 2 different synMuv B mutants produce 50–100× less Orsay virus RNA. by Ashwin Seetharaman (615458)

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Subjects:

SARS-CoV-2 induced lung inflammation is increased with IL-10 blockade and decreased with IFNγ blockade. by Christine E. Nelson (18946410)

Table_1_Decreased Serum Brain-Derived Neurotrophic Factor Concentrations 72 Hours Following Marathon Running.DOCX by Astrid Roeh (11136600)

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)

The experimental design of in vivo animal study. by Chi-Feng Chiang (16534951)

“…Seven days later, they received therapy with PLD (10 mg/kg) + pUH (3 MHz, 50% duty cycle, 0.65 W/cm², 15min) + CQ (50 mg/kg daily). …”

S1 Data - by Chi-Feng Chiang (16534951)

“…Seven days later, they received therapy with PLD (10 mg/kg) + pUH (3 MHz, 50% duty cycle, 0.65 W/cm², 15min) + CQ (50 mg/kg daily). …”

Serum samples and 50% NAI values. Serum samples taken from CEIRS study. by Harrison Powell (9040128)

The experimental set-up we used. by Hillary Jean-Joseph (9676166)

Image_1_Desmoglein-4 Deficiency Exacerbates Psoriasiform Dermatitis in Rats While Psoriasis Patients Displayed a Decreased Gene Expression of DSG4.TIF by Tamara Moreno-Sosa (10717320)

Image_2_Desmoglein-4 Deficiency Exacerbates Psoriasiform Dermatitis in Rats While Psoriasis Patients Displayed a Decreased Gene Expression of DSG4.TIF by Tamara Moreno-Sosa (10717320)

Detoxifying enzyme activities of slug larvae and adults treated with LC₅₀ for 24 and 48 h, respectively. by Haojun Li (11007721)